Delivery Order SPE2DB24D1205-SPE2DB25FCZYS
- Not listed
- The Defense Logistics Agency awarded a $3,697.14 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Multaq 400 mg tablets (60-count units). The contract, which is a non-set-aside competitive award, represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. Performance will take place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Multaq 400 mg tablets (60-count packages) valued at $11,622.61. This competitively awarded, firm fixed-price delivery order is set to be completed by October 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $24,960.51 with firm fixed pricing. This competitively awarded, non-set-aside contract is scheduled for completion by September 15, 2025, with performance of work occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $48,680.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Multaq 400 mg tablets (60-count units). This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order specifies a completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $3,418.56 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on October 15, 2025, with completion scheduled for October 16, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $1,529.88 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Multaq 400 mg tablets (60-count package). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $12,728.18. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The contract is scheduled for completion by November 28, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order valued at $17,446.83 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) under a firm fixed-price contract with an ultimate completion date of August 19, 2025. This non-set-aside delivery order represents a single procurement action drawn from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $11,602.70. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on April 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under the vendor's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Multaq 400 mg tablets (60-count units) at a ceiling value of $6,038.05 under a firm fixed-price contract. This is a non-set-aside award issued as a child delivery order, likely under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a maximum value of $999,999,999.00 through December 2026. The product will be...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZYSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $39,860.86 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on August 27, 2025, with completion targeted for August 28, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order executed under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, fulfills this order as part of its broader portfolio supporting military and veteran healthcare systems. The company maintains a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX) through December 2026, which serves as the framework for such delivery orders and enables the supply of a comprehensive range of pharmaceuticals and medical supplies to support defense healthcare programs globally. This specific delivery order for Multaq, an antiarrhythmic medication, reflects the company's role in providing specialized pharmaceutical products across multiple therapeutic domains to support federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.9k | 8/27/25 |